Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-02-18 @ 2:41 AM
Study NCT ID:
NCT03251768
Status:
COMPLETED
Last Update Posted:
2019-09-13
First Post:
2017-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients
Sponsor:
Tianjin SinoBiotech Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-07
First Submit QC Date:
None
Study First Post Date:
2017-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-12
Last Update Post Date:
2019-09-13
Last Update Post Date Type:
ACTUAL